BCL2 and cancer: NR4A1 is a nuclear receptor; however, treatment of some cancer cell lines with apoptosis-inducing agents results in the induction and nuclear export of NR4A1 which associates with mitochondrial bcl-2 to form a pro-apoptotic complex [18–20, 25].